It has also been reported that bone morphogenetic protein-2 (BMP-2) signalling activates STAT3 and promotes EMT and colon cancer stemness in CRC, which contribute to drug resistance (Kim et al., 2015). This evidence concerns the gene BMP2 and colonic neoplasm.